EP1045799B1 - Primary packaging unit for film-like or oblate-like administered shapes - Google Patents
Primary packaging unit for film-like or oblate-like administered shapes Download PDFInfo
- Publication number
- EP1045799B1 EP1045799B1 EP99902517A EP99902517A EP1045799B1 EP 1045799 B1 EP1045799 B1 EP 1045799B1 EP 99902517 A EP99902517 A EP 99902517A EP 99902517 A EP99902517 A EP 99902517A EP 1045799 B1 EP1045799 B1 EP 1045799B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- packaging material
- film
- packaging
- wafer
- primary packaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/40—Packages formed by enclosing successive articles, or increments of material, in webs, e.g. folded or tubular webs, or by subdividing tubes filled with liquid, semi-liquid, or plastic materials
- B65D75/42—Chains of interconnected packages
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/52—Details
- B65D75/527—Tear-lines for separating a package into individual packages
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B9/00—Enclosing successive articles, or quantities of material, e.g. liquids or semiliquids, in flat, folded, or tubular webs of flexible sheet material; Subdividing filled flexible tubes to form packages
- B65B9/02—Enclosing successive articles, or quantities of material between opposed webs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
- Y10T156/1089—Methods of surface bonding and/or assembly therefor of discrete laminae to single face of additional lamina
- Y10T156/1092—All laminae planar and face to face
- Y10T156/1093—All laminae planar and face to face with covering of discrete laminae with additional lamina
- Y10T156/1095—Opposed laminae are running length webs
Definitions
- the present invention relates to a method for producing a primary packaging unit for film-like or wafer-like dosage forms for oral Application. It affects in particular a method for producing a primary packaging unit, which from the film or wafer-like to be packed Dosage form and a section of each Upper and lower packaging material is formed.
- Forms of administration in film or wafer form for oral administration are u. a. from the patent or published documents US 3 007 848, DE 24 32 925, DE 27 46 414, EP 219 762 are known. They differ from conventional fixed dosage forms such as tablets or capsules in particular through their geometric shape and by their manufacture. You together is a thin, flat shape, being distinguished by differences in flexibility, brittleness, smoothness or consistency either a film or foil-like, a paper-like or results in an oblate character. For the production were especially those in industrial film production applied extrusion and coating processes recommended.
- rapidly decaying or quick-release variants for decay in the oral cavity immediately after application with release of an active ingredient where the term "rapidly disintegrating" in the sense of this invention to a disintegration time of a few seconds up to a few minutes under the influence of saliva should relate.
- Both basic types can be designed so that they are in Dependence on the incorporated active ingredient for a local Therapy of the oral mucosa or for systemic drug application are suitable.
- the packaging of these dosage forms in primary packaging units can not be easily with the for conventional pharmaceutical products such as capsules or tablets Carry out usual procedures, packaging materials or machines.
- a modern one Primary packaging unit for single dosage solid dosage forms on the one hand the product is intended to withstand external influences protect, on the other hand a conscious and verifiable removal a single dose unit at the desired time of intake allow, taking the dose unit from the primary packaging unit must be such that the dosage form is not damaged.
- Primary packaging units contain a plurality of dose units, each individually in a cavity between two packaging material web sections are sealed. The cavity is filled by hot or cold working before filling Bottom of packaging material with the help of an appropriate tool created. After filling the cavities, the top web of packaging material fed and sealed together with the bottom sheet.
- a dose unit is removed from modern blister packs in that on the outside of the deformed points the packaging material lower web and thus on the tablet or Capsule, which is in the created by the deformation Cavity, with which finger pressure is exerted, which is sufficient to break through the top web of packaging material and push out the dose unit.
- this is only then possible if the material of the packaging material upper web a certain Strength does not exceed.
- Oral dosage forms in the form of films or wafers are generally much lighter and less compact than conventional tablets or capsules, particularly in the case of the quick-release variants.
- the proposed dimensions of the film-like or wafer-like dose units are approximately 1 cm 2 (eg DE 27 46 414) to 3 cm 2 or more (eg DE 24 32 925) and a thickness of approximately 0.05 to 1 mm (e.g. DE 24 329 25).
- dose units with a mass of about 5 to 100 mg result, whereby the typical and preferred configurations are more likely to be in the lower sector of this range. It has now been shown that it is more difficult to insert such thin films or wafers in blisters.
- a primary packaging unit must additionally another feature is perforation between the compartments in which the individual Dose units are, and such a perforation that it enables, if necessary, the removal of a single dose unit first the compartment of this dose unit from the Remove the primary packaging unit in order to subsequently remove the To be able to open the compartment without further compartments to damage.
- the perforation also has the advantage that with the appropriate design, if possible with only a few, small breakpoints also allowed, one compartment without first separating it from the primary packaging unit targeted opening without additional compartments open at the same time.
- This primary packaging unit consists in the relatively small gas space of the compartments, in which the dose units are located. oxidation or Moisture sensitive products can therefore be used with suitable Choice of primary packaging materials largely before the harmful ones Protected against the effects of atmospheric oxygen and humidity become.
- Another advantage of this primary packaging unit is in the low packaging material requirement and the handy, see space-saving format. For example, let in a folding box of 1 cm in height 10 or more primary packaging units with 10 dose units each accommodate.
- Another advantage of this primary packaging unit exists in the possibility as a packaging material bottom sheet also use materials that are significantly thinner and cheaper are as such that are used to manufacture blister packs and are suitable for cold or hot working and a specific one Minimum thickness and, due to this, a minimum weight must have.
- This primary packaging unit consists in the possibility of printing on it Visualize therapy schemes. For example, a packaging unit as a weekly pack with 7 dose units produce a medicine to be taken once a day, the individual compartments of the packaging unit with the names or abbreviations of the days of the week are printed. Based patients can use this printed therapy scheme control your earnings very easily. In a preferred one The packaging unit contains imprints.
- the primary packaging unit contains sealing seams or sealing surfaces between the packaging material upper section and the - sub-web section, which are peelable. Peelable in the sense of this Invention encompasses all sealing seams or sealing surfaces that with moderate peel force, e.g. B. less than about 10 N / 15 mm, separated can be, usually the integrity of the Packaging material web sections are preserved.
- special sealing media e.g. B. So-called "Peel-PE"
- a special polyethylene which is usually contains another polymer such as polystyrene and special sealing conditions (pressure, time, temperature) used.
- Another embodiment of the Primary packaging unit provides that next to each compartment outside of the sealing surfaces or sealing seams there is an unsealed edge on at least one side. This serves as handle tabs to the section of the packaging material easily grasp the bottom web and the packaging materials underneath To be able to separate the opening of a compartment.
- these tabs or unsealed edges of different lengths for the Packaging material upper and lower web section. If one of the If it protrudes from both packaging material sections on the edge, it is special easy to grip and from the second packaging material web section to bend away, which then also makes it easier to grab is.
- Packaging material webs for the production of such primary packaging units can be single-layered, but are usually be multilayered in order to be able to meet the requirements to modern packaging materials and in connection with film or wafer-like dosage forms must be provided.
- Frequently occurring layers are e.g. B. Kraft paper for Generation of rigidity, plastic films for tensile strength and tightness of the packaging material, sealing wax for better Sealability, protective lacquers for impregnating the kraft paper, Aluminum for particularly high tightness, glue for the cohesion of individual layers, etc.
- Optimized Packaging material laminates contain from an economic point of view no more layers and no greater layer thicknesses than for the respective purpose is necessary.
- the upper and lower lanes can be attached different requirements are made.
- a Primary packaging e.g. B. have a certain minimum stiffness should - and used a preferred for better manageability
- Design of the primary packaging unit a packaging material web with a bending stiffness of at least x with a common minimum thickness of y ⁇ m - it is sufficient if this rigidity is mainly due to a the packaging material web is conveyed while the other packaging material web according to other economic or technical aspects can be optimized.
- Another variant of the primary packaging unit with two differently constructed packaging material webs contains a transparent packaging material section, through which the dosage units of the dosage form can see through the intact package. It is the definition of top and bottom rail arbitrary; for the purpose of This invention aims at using a transparent and a non-transparent packaging material web is the transparent one Path can be defined as the upper path.
- One of the advantages of this The variant is the simple visual inspection of the compartments or the dose units and their condition.
- Another The advantage is that there is a transparent top sheet printing on the top of the lower web or of dose units. Since such prints, such as already described, advantages u. a. regarding the revenue control have a variant of Primary packaging unit a transparent Packaging material upper web section and either one on the top-printed Lower web section or printed on the top Dosage units.
- Such packaging units are suitable for everyone film-like or wafer-like dosage forms that correspond to the stand are known in the art.
- FIG. 1 A manufacturing process schematically shown in Fig. 1, for packaging units with square or rectangular dose units (5) consists of at least the following principal ones Process steps together, if necessary by further Steps for printing, additional shaping of the packaging unit or the like.
- the first step is a top web of packaging material (1) and a bottom web (2) without cold or hot deformation via a deflection shaft (3) brought together, at the same time the film or wafer-like dosage form (4) with the help of roles or Pliers advantages (17) between the two packaging material webs to be led.
- the film or wafer-like Dosage form already as a web product - single lane or multi-lane parallel at a distance from each other - with the desired one Width of the dose units (5) is supplied. Equally beneficial is smaller than the diameter of the deflection shafts the length of the dose units in the direction of travel of the webs choose.
- dose units (5) from the sheet-like dosage form by a Cross cutting device (6) isolated, which immediately before the deflection shafts is positioned.
- the two packaging material webs with the help of a heated sealing tool (7) sealed against each other in such a way, that the individual dose units (5) in compartments (8) be sealed and completely by sealing seams or sealing surfaces (9) are surrounded.
- a further step are perforations through a punching device (12) stamped between the compartments (8).
- the process step can be carried out by primary packaging units (11) a second cross cutting or punching device can be divided.
- a manufacturing method according to the invention is shown schematically in Fig. 2.
- the ones described here Process steps can be supplemented if necessary.
- the procedure contains the provision of a laminate in one process step (13) from the web-like, film or wafer-like dosage form (4) and a carrier film (14), from which in one further step with a punching device (15) the dose units (5) are punched out without the carrier film (14) is punched through.
- the punched laminate (13) with the help of rolls or Pliers advantages (17) over an edge or deflection shaft (18) see above deflected that the dose units (5) from the carrier film Loosen (14). If necessary, this can also be done additionally a scraper (16) can be used.
- perforations between a punching device (12) the compartments (8) are stamped.
- primary packaging units (11) by a second cross cutting or punching device can be separated.
Landscapes
- Mechanical Engineering (AREA)
- Engineering & Computer Science (AREA)
- Packages (AREA)
- Wrappers (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Exposure Of Semiconductors, Excluding Electron Or Ion Beam Exposure (AREA)
- Formation Of Insulating Films (AREA)
- Dry Development In Electrophotography (AREA)
- Packaging For Recording Disks (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung einer Primärverpackungseinheit für film- oder oblatenartige Darreichungsformen zur oralen Applikation. Insbesondere betrifft sie ein Verfahren zur Herstellung einer Primärverpakkungseinheit, welche aus der zu verpackenden film- oder oblatenartigen Darreichungsform sowie jeweils einem Abschnitt einer Packstoffober- und einer -unterbahn gebildet wird.The present invention relates to a method for producing a primary packaging unit for film-like or wafer-like dosage forms for oral Application. It affects in particular a method for producing a primary packaging unit, which from the film or wafer-like to be packed Dosage form and a section of each Upper and lower packaging material is formed.
Film- oder oblatenartige Darreichungsformen zur oralen Applikation sind u. a. aus den Patent- bzw. Offenlegungsschriften US 3 007 848, DE 24 32 925, DE 27 46 414, EP 219 762 bekannt. Sie unterscheiden sich von konventionellen festen Darreichungsformen wie Tabletten oder Kapseln insbesondere durch ihre geometrische Form und durch ihre Herstellung. Ihnen gemeinsam ist eine dünne, flächige Formgebung, wobei sich durch Unterschiede in der Flexibilität, Sprödigkeit, Glätte oder Konsistenz entweder ein film- bzw. folienartiger, ein papierähnlicher oder ein oblatenartiger Charakter ergibt. Für die Herstellung wurden insbesondere die in der industriellen Folienproduktion angewandten Extrusions- und Beschichtungsverfahren empfohlen.Forms of administration in film or wafer form for oral administration are u. a. from the patent or published documents US 3 007 848, DE 24 32 925, DE 27 46 414, EP 219 762 are known. They differ from conventional fixed dosage forms such as tablets or capsules in particular through their geometric shape and by their manufacture. You together is a thin, flat shape, being distinguished by differences in flexibility, brittleness, smoothness or consistency either a film or foil-like, a paper-like or results in an oblate character. For the production were especially those in industrial film production applied extrusion and coating processes recommended.
Je nach Anwendungszweck bieten sich zwei Grundtypen der Ausgestaltung an. Zum einen gehören schnellzerfallende bzw. schnellfreisetzende Varianten für den Zerfall in der Mundhöhle unmittelbar nach der Applikation unter Freisetzung eines Wirkstoffes, wobei sich der Begriff "schnellzerfallend" im Sinne dieser Erfindung auf eine Zerfallszeit von einigen Sekunden bis zu maximal einigen Minuten unter Einwirkung von Speichelflüssigkeit beziehen soll. Zum anderen sind langsam oder praktisch gar nicht zerfallende Varianten bekannt, die sich insbesondere zur langsamen und kontinuierlichen Wirkstoffabgabe eignen und durch Zusatz von mucoadhäsiven Stoffen in der Lage sind, während der Wirkstoffabgabe an der Mundschleimhaut zu haften. Beide Grundtypen lassen sich so gestalten, daß sie in Abhängigkeit vom eingearbeiteten Wirkstoff für eine lokale Therapie der Mundschleimhaut oder für die systemische Wirkstoffapplikation geeignet sind.Depending on the application, there are two basic types of design on. On the one hand, rapidly decaying or quick-release variants for decay in the oral cavity immediately after application with release of an active ingredient, where the term "rapidly disintegrating" in the sense of this invention to a disintegration time of a few seconds up to a few minutes under the influence of saliva should relate. Second, they are slow or practical known non-decaying variants, which are particularly for the slow and continuous release of active ingredients suitable and capable by adding mucoadhesive substances are on the oral mucosa during drug delivery be liable. Both basic types can be designed so that they are in Dependence on the incorporated active ingredient for a local Therapy of the oral mucosa or for systemic drug application are suitable.
Die Konfektionierung dieser Darreichungsformen in Primärverpackungseinheiten läßt sich nicht ohne weiteres mit den für konventionelle pharmazeutische Produkte wie Kapseln oder Tabletten üblichen Verfahren, Packmitteln oder Maschinen bewerkstelligen. Eine unter modernen Gesichtspunkten konzipierte Primärverpackungseinheit für einzeldosierte feste Darreichungsformen soll einerseits das Produkt vor äußeren Einflüssen schützen, andererseits eine bewußte und nachprüfbare Entnahme einer einzigen Dosiseinheit zum gewünschten Einnahmezeitpunkt ermöglichen, wobei die Entnahme der Dosiseinheit aus der Primärverpackungseinheit so zu erfolgen hat, daß die Darreichungsform nicht beschädigt wird.The packaging of these dosage forms in primary packaging units can not be easily with the for conventional pharmaceutical products such as capsules or tablets Carry out usual procedures, packaging materials or machines. A modern one Primary packaging unit for single dosage solid dosage forms on the one hand, the product is intended to withstand external influences protect, on the other hand a conscious and verifiable removal a single dose unit at the desired time of intake allow, taking the dose unit from the primary packaging unit must be such that the dosage form is not damaged.
Während Tabletten und Kapseln häufig in größerer Anzahl in Gläser oder Dosen abgefüllt werden, was den genannten Anforderungen kaum genügen kann, ist es vielfach üblich, Dosiseinheiten in Blister- oder Tiefziehpackungen zu verpacken. Derartige Primärverpackungseinheiten enthalten eine Mehrzahl von Dosiseinheiten, die jeweils individuell in einen Hohlraum zwischen zwei Packstoffbahnabschnitten eingesiegelt werden. Der Hohlraum wird vor dem Befüllen durch Heiß- oder Kaltverformung der Packstoffunterbahn mit Hilfe eines entsprechenden Werkzeugs geschaffen. Nach dem Befüllen der Hohlräume wird die Packstoffoberbahn zugeführt und mit der Unterbahn zusammengesiegelt.While tablets and capsules are often in larger numbers Glasses or cans are filled, which meets the requirements mentioned barely enough, it is common for dose units to be packed in blister or thermoformed packs. such Primary packaging units contain a plurality of dose units, each individually in a cavity between two packaging material web sections are sealed. The cavity is filled by hot or cold working before filling Bottom of packaging material with the help of an appropriate tool created. After filling the cavities, the top web of packaging material fed and sealed together with the bottom sheet.
Die Entnahme einer Dosiseinheit erfolgt bei modernen Blisterpackungen dadurch, daß auf die Außenseite der verformten Stellen der Packstoffunterbahn und damit auf die Tablette oder Kapsel, die sich in dem durch die Verformung geschaffenen Hohlraum befindet, mit dem Finger ein Druck ausgeübt wird, welcher ausreichend ist, um die Packstoffoberbahn zu durchbrechen und die Dosiseinheit herauszudrücken. Dies ist jedoch nur dann möglich, wenn das Material der Packstoffoberbahn eine bestimmte Festigkeit nicht überschreitet.A dose unit is removed from modern blister packs in that on the outside of the deformed points the packaging material lower web and thus on the tablet or Capsule, which is in the created by the deformation Cavity, with which finger pressure is exerted, which is sufficient to break through the top web of packaging material and push out the dose unit. However, this is only then possible if the material of the packaging material upper web a certain Strength does not exceed.
Dieses Konzept für Primärverpackungseinheiten hat zwar für konventionelle Darreichungsformen eine weite Verbreitung gefunden, ist aber für Darreichungsformen mit film- oder oblatenartiger Ausgestaltung mit erheblichen Nachteilen verbunden. Bei hierzu durchgeführten Versuchen haben sich zwei Nachteile als besonders gravierend herausgestellt, von denen einer das Herstellen, der andere die Entnahme von Dosiseinheiten aus Primärverpackungseinheiten dieser Art betrifft.This concept for primary packaging units has for conventional dosage forms found widespread use, but is for dosage forms with film or wafer-like Design associated with significant disadvantages. There are two disadvantages in experiments carried out for this turned out to be particularly serious, one of which is the Manufacture the other from taking dose units Primary packaging units of this type concerns.
Bei film- oder oblatenartigen oralen Darreichungsformen handelt es sich in der Regel - insbesondere bei den schnellfreisetzenden Varianten - um sehr viel leichtere und weniger kompakte als bei konventionellen Tabletten oder Kapseln. Die vorgeschlagenen Abmessungen der film- oder oblatenartigen Dosiseinheiten liegen bei circa 1 cm2 (z. B. DE 27 46 414) bis 3 cm2 oder mehr (z. B. DE 24 32 925) und einer Dicke von etwa 0,05 bis 1 mm (z. B. DE 24 329 25). Bei der Verwendung der üblichen pharmazeutischen Grundstoffe ergeben sich demnach Dosiseinheiten mit einer Masse von etwa 5 bis 100 mg, wobei die typischen und bevorzugten Ausgestaltungen eher im unteren Sektor dieser Spanne liegen dürften. Nun hat es sich gezeigt, daß es mit größeren Schwierigkeiten verbunden ist, solch dünne Filme oder Oblaten in Blister einzulegen. Insbesondere bei höheren Maschinengeschwindigkeiten bewirken Luftbewegung, verursacht durch sich bewegende Maschinenteile, und häufig auch eine elektrostatische Aufladung der Packstoffe, daß sich die Dosiseinheiten nicht korrekt im Blister positionieren lassen oder nach der Positionierung wieder aus dem Blister geweht werden. Wenn es auch durchaus möglich ist, tiefgezogene Primärverpackungseinheiten mit oralen Filmen oder Oblaten herzustellen, so ist es dennoch aufgrund der dargestellten Probleme ein aufwendiges und wenig effizientes Verpackungskonzept. Oral dosage forms in the form of films or wafers are generally much lighter and less compact than conventional tablets or capsules, particularly in the case of the quick-release variants. The proposed dimensions of the film-like or wafer-like dose units are approximately 1 cm 2 (eg DE 27 46 414) to 3 cm 2 or more (eg DE 24 32 925) and a thickness of approximately 0.05 to 1 mm (e.g. DE 24 329 25). When using the usual pharmaceutical raw materials, dose units with a mass of about 5 to 100 mg result, whereby the typical and preferred configurations are more likely to be in the lower sector of this range. It has now been shown that it is more difficult to insert such thin films or wafers in blisters. Especially at higher machine speeds, air movement caused by moving machine parts and often also an electrostatic charging of the packaging materials mean that the dose units cannot be positioned correctly in the blister or are blown out of the blister after positioning. Although it is entirely possible to manufacture deep-drawn primary packaging units with oral films or wafers, it is nevertheless a complex and inefficient packaging concept due to the problems presented.
Die Entnahme der film- oder oblatenartigen Darreichungsformen aus Blisterpackungen, die den konventionellen Primärverpackungen für Tabletten oder Kapseln entsprechen, ist ebenfalls problematisch. Eine in einer Vertiefung liegende flächige Dosiseinheit kann kaum durch das Material der Packstoffoberbahn gedrückt werden; dazu besitzt sie weder das notwendige Format noch die mechanische Festigkeit. Die Gefahr, die Dosiseinheit beim Herausdrücken zu beschädigen, ist relativ groß. Selbst wenn man versucht, das Material der Packstoffoberbahn zunächst auf andere Art, z. B. mit dem Fingernagel zu durchbrechen, ist es nicht einfach, eine flache Dosiseinheit in der offengelegten Vertiefung zu greifen und zu entnehmen, es sei denn, man wählt sehr große Vertiefungen, was aus anderen Gründen wie etwa dem zu großen eingeschlossenen Luftraum im Verhältnis zur geringen Masse der Darreichungsform nachteilig ist.The removal of the film or wafer-like dosage forms from blister packs, which are the conventional primary packaging to match for tablets or capsules is also problematic. A flat dose unit lying in a recess can hardly through the material of the packaging material be pressed; it does not have the necessary format for this nor the mechanical strength. The danger, the dose unit Damaging when pushed out is relatively large. Self if you try the material of the upper packaging material first in another way, e.g. B. to break through with your fingernail it is not easy to disclose a flat dose unit in the To grasp and extract, unless one chooses very large wells, for other reasons such as the too large enclosed air space in relation to the low mass of the dosage form is disadvantageous.
Zusätzliche Schwierigkeiten bei der konventionellen Konfektionierung ergeben sich dann, wenn die film- oder oblatenartigen Darreichungsformen eine eher brüchige, zerbrechliche Beschaffenheit aufweisen. In diesem Fall kann eine formsteife Blisterverpackung zwar einen gewissen Produktschutz während der Lagerung gewährleisten, macht jedoch die Entnahme der Dosiseinheiten umso schwerer.Additional difficulties with conventional packaging arise when the film or wafer-like Dosage forms a rather fragile, fragile nature exhibit. In this case, a rigid blister pack some product protection during Ensuring storage, however, makes the withdrawal of the dose units all the more difficult.
Abgesehen von diesen Nachteilen konventioneller Blisterverpakkungen für film- oder oblatenartige Darreichungsformen ist die Auswahl an geeigneten Packmaterialien für Blisterpackungen begrenzt; die verfügbaren Materialien gehören außerdem nicht zu den besonders kostengünstigen Packstoffen.Apart from these disadvantages of conventional blister packaging for film or wafer-like dosage forms Limited choice of suitable packaging materials for blister packs; the available materials are also not included the particularly inexpensive packaging materials.
Einige Lösungsansätze zur Schaffung einer Primärverpackungseinheit für film- oder oblatenartigen Darreichungsformen ohne die beschriebenen Nachteile des Standes der Technik finden sich in US 3 007 848. Die hier dargestellten Lösungsansätze sind für alle film- und oblatenartigen Darreichungsformen teilweise interessant, obwohl sich US 3 007 848 im Unterschied zu der vorliegenden Erfindung im engeren Sinne auf (1) durch Extrusion oder durch Bedruckung eßbarer Folien hergestellte Oblaten bezieht, welche (2) nicht zur Anwendung im Mundraum, sondern zum Verschlucken bestimmt sind und (3) hierzu optional zunächst in Folienstreifen von einer eßbaren, glatten und leicht zu verschluckenden Folie eingesiegelt werden. Dennoch lehrt die zitierte Schrift das Verpacken von Oblaten durch Einsiegeln der Dosiseinheiten zwischen zwei Folien, welche im verallgemeinerten Sinne als Packstoffe zu verstehen sind. Darüber hinaus lehrt sie das nur "leichte" Einsiegeln der Dosiseinheiten zur einfacheren Öffnung der Kompartimente und zur Entnahme der Oblaten. Schließlich offenbart sie ebenso einen ungesiegelten Randbereich im Packmaterial, der das Anfassen der Packstofffolien und das Auseinanderziehen zur Entnahme der Oblaten erleichtert.Some approaches to creating a primary packaging unit for film or wafer-like dosage forms without find the described disadvantages of the prior art in US 3 007 848. The approaches presented here are for all film and wafer-like dosage forms partly interesting, although US 3 007 848 differs to the present invention in the narrower sense on (1) Extrusion or produced by printing edible foils Obtains wafers which (2) are not for use in the mouth, but are intended for ingestion and (3) optional first in foil strips of an edible, smooth and easy to swallow foil. Yet the cited document teaches the packaging of wafers Sealing the dose units between two foils, which in the generalized senses are to be understood as packaging materials. About that she also teaches the "light" sealing of the dose units for easier opening of the compartments and Removal of the wafers. Finally, it also reveals one unsealed edge area in the packing material, which is touching the packaging films and pulling them apart to remove the Relieved wafers.
Dennoch sind auch in US 3 007 848, welche einen der vorliegenden Erfindung nahestehenden Stand der Technik darstellt, nicht alle Anforderungen für eine geeignete Primärverpackungseinheit für film- oder oblatenartigen Darreichungsformen erfüllt; einige Nachteile und Probleme bleiben ungelöst bzw. entstehen erst durch die vorgeschlagene Ausgestaltung der Verpackungseinheit.Nevertheless, US 3 007 848, which is one of the present Is not related to the prior art all requirements for a suitable primary packaging unit fulfilled for film or wafer-like dosage forms; some Disadvantages and problems remain unsolved or arise only through the proposed design of the packaging unit.
Zum einen enthält die dort vorgeschlagene Verpackungseinheit jeweils nur eine Oblate, wenn man von dem Zwischenprodukt absieht, welches eine nicht definierte, jedoch sehr große Anzahl von verpackten Dosiseinheiten sozusagen als aufrollbare Bandware darstellt. Eine praktikable Primärverpackungseinheit soll im Regelfall jedoch aus verschiedenen Gründen eine klar definierte Mehrzahl von Dosiseinheiten enthalten. Aus der Nichteinhaltung dieser Forderung ergeben sich deutliche Nachteile für die Sekundärverpackung: Zunächst müssen die nach US 3 007 848 abgetrennten kleinen Primärverpackungseinheiten mit je einer Oblate gefüllt, gesammelt, zu Packungsgrößen von beispielsweise 20 Stück gezählt und zusammengefaßt werden, was mit erheblichem Aufwand verbunden ist und zu unhandlichen Sekundärverpackungsformaten führt. Zur späteren Entnahme müßte jeweils eine Primärverpackungseinheit herausgenommen, geöffnet und die Oblate entnommen werden, wobei die Kontrolle über die bis zu einem bestimmten Zeitpunkt erfolgten Einnahmen sehr schwierig ist. Beispielsweise wird es bei einer Sekundärverpackungseinheit mit 50 Oblaten kaum möglich sein, ohne aufwendiges Nachzählen der noch vorhandenen Oblaten zu überblicken, ob eine bestimmte fällige Einnahme schon erfolgte oder nicht.Firstly, it contains the packaging unit proposed there only one wafer at a time, apart from the intermediate product, which is an undefined but very large number of packaged dose units, so to speak, as rollable tape goods represents. A practical primary packaging unit should usually a clearly defined one for various reasons Contain a plurality of dose units. From non-compliance There are clear disadvantages to this requirement for secondary packaging: First, the after US 3 007 848 separated small primary packaging units filled with a wafer, collected, in pack sizes of for example, 20 pieces are counted and summarized what is associated with considerable effort and unwieldy secondary packaging formats leads. Should have to be removed later one primary packaging unit removed, opened and the wafer are removed, taking control of the up to a certain point in time, earnings were very high is difficult. For example, it will be in a secondary packaging unit with 50 wafers would be hardly possible without extensive Overview of the remaining wafers, whether a certain due date has already been taken or not.
Es ist daher die Aufgabe der vorliegenden Erfindung, ein Verfahren zur Herstellung einer Primärverpackungseinheit für film- oder oblatenartige Darreichungsformen zu schaffen, die allen genannten Anforderungen genügt, ohne die beschriebenen Nachteile des Standes der Technik aufzuweisen.It is therefore the object of the present invention a method for producing a primary packaging unit for film or wafer-like dosage forms to create all the requirements mentioned is sufficient without the disadvantages of the prior art described exhibit.
Die Lösung der Aufgabe geschieht durch das Verfahren nach Anspruch 1. Mittels dieses Verfahren kann eine Primärverpackungseinheit für film- oder oblatenartige Darreichungsformen zur oralen Applikation mit je einem Abschnitt einer Packstoffober- und -unterbahn hergestellt werden, bei der, mehrere Dosiseinheiten einer film- oder oblatenartigen Darreichungsform im Abstand zueinander einzeln in flachen, ohne Kalt- oder Heißverformung des Packmaterials erzeugten Kompartimenten eingesiegelt in einer Primärverpackungseinheit vorliegen, und beider sich zwischen den Kompartimenten Perforationen befinden, welche die bedarfsweise Abtrennung einzelner Kompartimente ermöglichen.The problem is solved by the method according to claim 1 Primary packaging unit for film or wafer-like dosage forms for oral application with one section each a packaging material top and bottom web are produced in which several dose units of a film or wafer-like Dosage form at a distance from each other individually in flat, produced without cold or hot deformation of the packaging material Compartments sealed in a primary packaging unit are present, and both are perforations between the compartments are located, which require the separation of individual Enable compartments.
Die Verfahrensschritte des Anspruchs 1 sind notwendig, um zu der geforderten,
praktikablen Primärverpackungseinheit zu kommen. Es
läßt sich nämlich das Konzept aus US 3 007 848 nicht ohne weiteres
nur dahingehend variieren, daß aus dem Zwischenprodukt,
welches z. B. als Rollen- oder Bandware vorliegt, durch Zerschneiden
derselben - nicht, wie gefordert, nach jeder Oblate,
sondern etwa nur nach jeder zehnten Oblate die Lösung schon
erreicht wäre. Eine so gewonnene Verpackungseinheit enthielte
zwar eine definierte Mehrzahl von Dosiseinheiten; diese könnten
allerdings nicht auf einfache Weise und ohne Probleme entnommen
werden. Versuche haben gezeigt, daß beim Öffnen einer
solchen Verpackung zur Entnahme einer Dosiseinheit im Regelfall
die Siegelnähte oder Siegelflächen um mehrere Dosiseinheiten
herum gleichzeitig geöffnet werden, so daß mehrere
Dosiseinheiten offenliegen und durch die Primärverpackung
nicht mehr geschützt werden. Die gezielte Entnahme einer einzigen
Dosiseinheit mittels Durchdrücken durch den Primärpackstoff
ist ja, wie oben beschrieben, aufgrund der geringen mechanischen
Festigkeit der Darreichungsform im Verhältnis zum
Primärpackstoff ebenfalls nicht möglich.The method steps of
Eine Primärverpackungseinheit muß zusätzlich ein weiteres Merkmal aufweisen nämlich eine Perforation zwischen den Kompartimenten, in denen sich die einzelnen Dosiseinheiten befinden, und zwar eine solche Perforation, die es ermöglicht, bedarfsweise zur Entnahme einer einzelnen Dosiseinheit zunächst das Kompartiment dieser Dosiseinheit aus der Primärverpackungseinheit herauszutrennen, um anschließend das Kompartiment öffnen zu können, ohne weitere Kompartimente zu beschädigen. Die Perforation bietet außerdem den Vorteil, daß sie es bei entsprechender Ausgestaltung mit möglichst nur wenigen, kleinen Haltepunkten ebenfalls gestattet, ein Kompartiment ohne dessen vorherige Heraustrennung aus der Primärverpackungseinheit gezielt zu öffnen, ohne weitere Kompartimente gleichzeitig zu öffnen.A primary packaging unit must additionally another feature is perforation between the compartments in which the individual Dose units are, and such a perforation that it enables, if necessary, the removal of a single dose unit first the compartment of this dose unit from the Remove the primary packaging unit in order to subsequently remove the To be able to open the compartment without further compartments to damage. The perforation also has the advantage that with the appropriate design, if possible with only a few, small breakpoints also allowed, one compartment without first separating it from the primary packaging unit targeted opening without additional compartments open at the same time.
Ein weiterer Vorteil dieser Primärverpackungseinheit besteht in dem relativ kleinen Gasraum der Kompartimente, in denen sich die Dosiseinheiten befinden. Oxidationsoder feuchtigkeitsempfindliche Produkte können daher bei geeigneter Wahl der Primärpackstoffe weitgehend vor den schädlichen Einflüssen von Luftsauerstoff und Luftfeuchte geschützt werden.Another advantage of this primary packaging unit consists in the relatively small gas space of the compartments, in which the dose units are located. oxidation or Moisture sensitive products can therefore be used with suitable Choice of primary packaging materials largely before the harmful ones Protected against the effects of atmospheric oxygen and humidity become.
Ein weiterer Vorteil dieser Primärverpackungseinheit
ist in dem geringen Packstoffbedarf und dem handlichen,
platzsparenden Format zu sehen. Beispielsweise lassen
sich in einer Faltschachtel von 1 cm Höhe ohne weiteres 10
oder mehr Primärverpackungseinheiten mit je 10 Dosiseinheiten
unterbringen.Another advantage of this primary packaging unit
is in the low packaging material requirement and the handy,
see space-saving format. For example, let
in a folding box of 1 cm in
Ein weiterer Vorteil dieser Primärverpackungseinheit besteht in der Möglichkeit, als Packstoffunterbahn auch Materialien einzusetzten, die deutlich dünner und billiger sind als solche, die zur Herstellung von Blisterpackungen und zur Kalt- oder Heißverformung geeignet sind und eine bestimmte Mindestdicke und, dadurch bedingt, ein Mindestgewicht aufweisen müssen.Another advantage of this primary packaging unit exists in the possibility as a packaging material bottom sheet also use materials that are significantly thinner and cheaper are as such that are used to manufacture blister packs and are suitable for cold or hot working and a specific one Minimum thickness and, due to this, a minimum weight must have.
Ein weiterer Vorteil dieser Primärverpackungseinheit besteht in der Möglichkeit, auf ihr durch Aufdrucke Therapieschemata zu visualisieren. So läßt sich beispielsweise eine Verpackungseinheit als Wochenpackung mit 7 Dosiseinheiten eines einmal täglich einzunehmenden Arzneimittels herstellen, wobei die einzelnen Kompartimente der Verpackungseinheit mit den Namen oder Abkürzungen der Wochentage bedruckt sind. Anhand dieses aufgedruckten Therapieschemas können Patienten sehr einfach ihre Einnahmen kontrollieren. In einer bevorzugten Ausführung enthält die Verpackungseinheit Aufdrucke.Another advantage of this primary packaging unit consists in the possibility of printing on it Visualize therapy schemes. For example, a packaging unit as a weekly pack with 7 dose units produce a medicine to be taken once a day, the individual compartments of the packaging unit with the names or abbreviations of the days of the week are printed. Based patients can use this printed therapy scheme control your earnings very easily. In a preferred one The packaging unit contains imprints.
Da film- oder oblatenartige Darreichungsformen, wie z. B. in DE 24 32 925 beschrieben, besonders vorteilhaft zunächst als Gießfolie hergestellt werden, aus der die Dosiseinheiten durch Schneiden oder Stanzen gewonnen werden können, enthält eine weitere Ausführungsform der Primärverpackungseinheit Dosiseinheiten, welche Abschnitte oder Stanzlinge von Gießfolien darstellen. Gießfolien im Sinne dieser Erfindung schließen alle folienartigen Zubereitungen ein, welche durch das Gießen von Trägermaterialien oder deren Beschichten mit polymerhaltigen Lösungen, Suspensionen oder Emulsionen mit anschließender Trocknung erzeugt wurden.Since film or wafer-like dosage forms such. B. in DE 24 32 925 described, particularly advantageous first as Cast film are made from which the dose units go through Cutting or punching can be obtained contains one further embodiment of the primary packaging unit Dose units which sections or Represent die cuts from cast films. Casting films in the sense of this Invention include all sheet-like preparations which by casting carrier materials or coating them with polymer-containing solutions, suspensions or Emulsions with subsequent drying were generated.
Eine weitere Ausführungsform der Primärverpackungseinheit enthält Siegelnähte oder Siegelflächen zwischen dem Packstoffoberbahnabschnitt und dem - unterbahnabschnitt, welche peelbar sind. Peelbar im Sinne dieser Erfindung umfaßt alle Siegelnähte oder Siegelflächen, die mit mäßiger Abziehkraft, z. B. weniger als ca. 10 N/15 mm, getrennt werden können, wobei in der Regel die Integrität der Packstoffbahnabschnitte erhalten bleibt. Zur Erzeugung solcher peelbarer Siegelnähte werden spezielle Siegelmedien, z. B. sog. "Peel-PE", ein spezielles Polyethylen, welches in der Regel ein weiteres Polymer wie etwa Polystyrol enthält, verwendet und spezielle Siegelbedingungen (Druck, Zeit, Temperatur) eingesetzt. Es ist jedoch auch möglich, konventionelle Siegelmedien unter solchen Bedingungen zu siegeln, daß kein Verbund in Form einer durchgeschmolzenen Siegelnaht, sondern eine peelbare Naht entsteht.Another embodiment of the The primary packaging unit contains sealing seams or sealing surfaces between the packaging material upper section and the - sub-web section, which are peelable. Peelable in the sense of this Invention encompasses all sealing seams or sealing surfaces that with moderate peel force, e.g. B. less than about 10 N / 15 mm, separated can be, usually the integrity of the Packaging material web sections are preserved. To generate such peelable sealing seams are special sealing media, e.g. B. So-called "Peel-PE", a special polyethylene, which is usually contains another polymer such as polystyrene and special sealing conditions (pressure, time, temperature) used. However, it is also possible to use conventional sealing media to seal under such conditions that no bond in the form of a melted sealed seam, but one peelable seam is created.
Eine weitere Ausführungsform der Primärverpackungseinheit sieht vor, daß sich neben jedem Kompartiment außerhalb der Siegelflächen oder Siegelnähte auf mindestens einer Seite ein ungesiegelter Rand befindet. Dieser dient als Anfaßlaschen dazu, den Abschnitt der Packstoffoberund der -unterbahn leicht greifen und die Packstoffe unter Öffnung eines Kompartimentes trennen zu können. In einer weiterhin Ausführungsform sind diese Anfaßlaschen bzw. ungesiegelten Ränder jeweils unterschiedlich lang für den Packstoffober- und -unterbahnabschnitt. Wenn nämlich einer der beiden Packstoffbahnabschnitte am Rand übersteht, ist er besonders leicht zu greifen und von dem zweiten Packstoffbahnabschnitt wegzubiegen, wodurch auch dieser dann leichter zu greifen ist.Another embodiment of the Primary packaging unit provides that next to each compartment outside of the sealing surfaces or sealing seams there is an unsealed edge on at least one side. This serves as handle tabs to the section of the packaging material easily grasp the bottom web and the packaging materials underneath To be able to separate the opening of a compartment. In a continued Embodiment are these tabs or unsealed edges of different lengths for the Packaging material upper and lower web section. If one of the If it protrudes from both packaging material sections on the edge, it is special easy to grip and from the second packaging material web section to bend away, which then also makes it easier to grab is.
Packstoffbahnen zur Herstellung solcher Primärverpackungseinheiten können einschichtig, werden aber in der Regel mehrschichtig sein, um die Anforderungen erfüllen zu können, die an moderne Packstoffe und im Zusammenhang mit filmoder oblatenartigen Darreichungsformen gestellt werden müssen. Häufig vorkommende Schichten sind dabei z. B. Kraftpapier zur Erzeugung von Steifigkeit, Kunststoffolien für die Zugfestigkeit und Dichtigkeit des Packstoffes, Siegellacke zur besseren Siegelfähigkeit, Schutzlacke zur Imprägnierung des Kraftpapiers, Aluminium für eine besonders hohe Dichtigkeit, Leime für den Zusammenhalt einzelner Schichten, u.s.w.. Optimierte Packstofflaminate enthalten unter ökonomischen Gesichtspunkten nicht mehr Schichten und keine größeren Schichtdicken als für den jeweiligen Zweck notwendig ist.Packaging material webs for the production of such primary packaging units can be single-layered, but are usually be multilayered in order to be able to meet the requirements to modern packaging materials and in connection with film or wafer-like dosage forms must be provided. Frequently occurring layers are e.g. B. Kraft paper for Generation of rigidity, plastic films for tensile strength and tightness of the packaging material, sealing wax for better Sealability, protective lacquers for impregnating the kraft paper, Aluminum for particularly high tightness, glue for the cohesion of individual layers, etc. Optimized Packaging material laminates contain from an economic point of view no more layers and no greater layer thicknesses than for the respective purpose is necessary.
In bestimmten Fällen wird es notwendig sein, für eine Primärverpackungseinheit ein bestimmtes Packstofflaminat sowohl als Packstoffoberbahn als auch als - unterbahn einzusetzen. Wenn beispielsweise eine besonders hohe Gasdichtigkeit erforderlich ist, wie sie nur mit einer Sperrschicht aus Aluminium erzielt werden kann, wird man dieses Element in beiden Packstoffbahnen benötigen.In certain cases it will be necessary for one Primary packaging unit a certain packaging laminate both as a packaging material topsheet and as - use subway. If, for example, a particularly high one Gas tightness is required as only with a barrier layer can be achieved from aluminum, this becomes Need element in both packaging material webs.
In anderen Fällen können jedoch an die Oberbahn und die Unterbahn unterschiedliche Anforderungen gestellt werden. Wenn eine Primärverpackung z. B. eine bestimmte Mindeststeifigkeit haben soll - und zur besseren Handhabbarkeit verwendet eine bevorzugte Ausgestaltungsform der Primärverpakkungseinheit eine Packstoffbahn mit einer Biegesteifigkeit von mindestens x bei einer gemeinsamen Mindeststärke von y µm - reicht es aus, wenn diese Steifigkeit vorwiegend durch eine der Packstoffbahnen vermittelt wird, während die andere Packstoffbahn nach anderen ökonomischen oder technischen Gesichtspunkten optimiert sein kann.In other cases, however, the upper and lower lanes can be attached different requirements are made. When a Primary packaging e.g. B. have a certain minimum stiffness should - and used a preferred for better manageability Design of the primary packaging unit a packaging material web with a bending stiffness of at least x with a common minimum thickness of y µm - it is sufficient if this rigidity is mainly due to a the packaging material web is conveyed while the other packaging material web according to other economic or technical aspects can be optimized.
Eine weitere Variante der Primärverpackungseinheit mit zwei unterschiedlich aufgebauten Packstoffbahnen enthält einen transparenten Packstoffoberbahnabschnitt, durch den die Dosiseinheiten der Darreichungsform durch die unversehrte Packung hindurch sehen kann. Dabei ist die Definition von Ober- und Unterbahn willkürlich; im Sinne dieser Erfindung soll bei einer Verwendung einer transparenten und einer nicht transparenten Packstoffbahn die transparente Bahn als Oberbahn definiert werden. Einer der Vorteile dieser Variante ist die einfache visuelle Überprüfbarkeit der Kompartimente bzw. der Dosiseinheiten und ihres Zustandes. Ein weiterer Vorteil ist, daß sich durch eine transparente Oberbahn hindurch eine Bedruckung der Oberseite der Unterbahn oder auch der Dosiseinheiten erkennen läßt. Da solche Bedruckungen, wie bereits beschrieben, Vorteile u. a. hinsichtlich der Einnahmekontrolle aufweisen, enthält eine Variante der Primärverpackungseinheit einen transparenten Packstoffoberbahnabschnitt und entweder einen auf der Oberseite-bedruckten Unterbahnabschnitt oder auf der Oberseite bedruckte Dosiseinheiten.Another variant of the primary packaging unit with two differently constructed packaging material webs contains a transparent packaging material section, through which the dosage units of the dosage form can see through the intact package. It is the definition of top and bottom rail arbitrary; for the purpose of This invention aims at using a transparent and a non-transparent packaging material web is the transparent one Path can be defined as the upper path. One of the advantages of this The variant is the simple visual inspection of the compartments or the dose units and their condition. Another The advantage is that there is a transparent top sheet printing on the top of the lower web or of dose units. Since such prints, such as already described, advantages u. a. regarding the revenue control have a variant of Primary packaging unit a transparent Packaging material upper web section and either one on the top-printed Lower web section or printed on the top Dosage units.
Solche Verpackungseinheiten eignen sich für alle film- oder oblatenartigen Darreichungsformen, die dem Stand der Technik bekannt sind. Hierzu gehören einfache, einschichtige Zubereitungen, die in der Regel im Speichel schnell zerfallen, jedoch auch mehrschichtige Systeme, die über längere Zeit an der Schleimhaut haften und ihren Wirkstoff abgeben, und deren Schichten dementsprechend unterschiedlich zusammengesetzt sind, wobei mindestens eine Schicht im Speichel langsam oder gar nicht zerfallsfähig ist und eine weitere Schicht mucoadhäsive Eigenschaften aufweist.Such packaging units are suitable for everyone film-like or wafer-like dosage forms that correspond to the stand are known in the art. This includes simple, single-layer Preparations that usually disintegrate quickly in saliva, however, multi-layer systems that last longer Stick to the mucous membrane and release its active ingredient, and accordingly their layers are composed differently are slow, with at least one layer in the saliva or is not decayable at all and another layer has mucoadhesive properties.
Solche Primärverpackungseinheiten lassen sich überraschend effizient maschinell fertigen. Ein Herstellverfahren, schematisch in Fig. 1 dargestellt, für Verpakkungseinheiten mit quadratischen oder rechteckigen Dosiseinheiten (5) setzt sich aus mindestens den folgenden prinzipiellen Verfahrensschritten zusammen, die bedarfsweise durch weitere Schritte zur Bedruckung, zusätzlichen Formgebung der Verpackungseinheit o. ä., ergänzt werden. Dabei werden in einem ersten Schritt eine Packstoffoberbahn (1) und eine -unterbahn (2) ohne Kalt- oder Heißverformung über jeweils eine Umlenkwelle (3) aufeinandergeführt, wobei gleichzeitig die filmoder oblatenartige Darreichungsform (4) mit Hilfe von Rollenoder Zangenvorzügen (17) zwischen die beiden Packstoffbahnen geführt wird. Vorteilhaft ist es, wenn die film- oder oblatenartige Darreichungsform bereits als Bahnware - einbahnig oder mehrbahnig parallel im Abstand zueinander - mit der gewünschten Breite der Dosiseinheiten (5) zugeführt wird. Ebenso vorteilhaft ist es, den Durchmesser der Umlenkwellen kleiner als die Länge der Dosiseinheiten in Laufrichtung der Bahnen zu wählen. In einem weiteren Verfahrensschritt werden Dosiseinheiten (5) aus der bahnförmigen Darreichungsform durch eine Querschneidevorrichtung (6) vereinzelt, welche unmittelbar vor den Umlenkwellen positioniert ist. In einem weiteren Verfahrensschritt werden die beiden Packstoffbahnen mit Hilfe eines beheizten Siegelwerkzeugs (7) derart gegeneinander gesiegelt, daß die vereinzelten Dosiseinheiten (5) in Kompartimenten (8) eingesiegelt werden und vollständig von Siegelnähten bzw. Siegelflächen (9) umgeben sind. In einem weiteren Verfahrensschritt werden durch eine Stanzvorrichtung (12) Perforationen zwischen den Kompartimenten (8) eingestanzt. In einem weiteren Verfahrensschritt können Primärverpackungseinheiten (11) durch eine zweite Querschneide- oder Stanzvorrichtung abgeteilt werden.Such primary packaging units can be surprising efficient machine production. A manufacturing process schematically shown in Fig. 1, for packaging units with square or rectangular dose units (5) consists of at least the following principal ones Process steps together, if necessary by further Steps for printing, additional shaping of the packaging unit or the like. Here are in one the first step is a top web of packaging material (1) and a bottom web (2) without cold or hot deformation via a deflection shaft (3) brought together, at the same time the film or wafer-like dosage form (4) with the help of roles or Pliers advantages (17) between the two packaging material webs to be led. It is advantageous if the film or wafer-like Dosage form already as a web product - single lane or multi-lane parallel at a distance from each other - with the desired one Width of the dose units (5) is supplied. Equally beneficial is smaller than the diameter of the deflection shafts the length of the dose units in the direction of travel of the webs choose. In a further process step, dose units (5) from the sheet-like dosage form by a Cross cutting device (6) isolated, which immediately before the deflection shafts is positioned. In a further step the two packaging material webs with the help of a heated sealing tool (7) sealed against each other in such a way, that the individual dose units (5) in compartments (8) be sealed and completely by sealing seams or sealing surfaces (9) are surrounded. In a further step are perforations through a punching device (12) stamped between the compartments (8). In another The process step can be carried out by primary packaging units (11) a second cross cutting or punching device can be divided.
Ein erfindungsgemäße Herstellverfahren ist in Fig. 2 schematisch dargestellt. Die hier beschriebenen Verfahrensschritte lassen sich bedarfsweise ergänzen. Das Verfahren enthält in einem Verfahrensschritt die Bereitstellung eines Laminates (13) aus der bahnförmigen, film- oder oblatenartigen Darreichungsform (4) und einer Trägerfolie (14), aus dem in einem weiteren Schritt mit einer Stanzvorrichtung (15) die Dosiseinheiten (5) ausgestanzt werden, ohne daß dabei die Trägerfolie (14) durchgestanzt wird. In einem weiteren Verfahrensschritt wird das angestanzte Laminat (13) mit Hilfe von Rollen- oder Zangenvorzügen (17) über eine Kante oder Umlenkwelle (18) so umgelenkt, daß sich dabei die Dosiseinheiten (5) von der Trägerfolie (14) lösen. Bedarfsweise kann hierzu auch zusätzlich ein Abstreifer (16) verwendet werden. In einem weiteren Verfahrensschritt werden eine Packstoffoberbahn (1) und eine - unterbahn (2) ohne Kalt- oder Heißverformung über jeweils eine Umlenkwelle (3) aufeinandergeführt, wobei gleichzeitig die sich von der Trägerfolie (14) ablösenden Dosiseinheiten (5) zwischen die beiden Packstoffbahnen (1 und 2) geführt werden. In einem weiteren Verfahrensschritt werden die beiden Packstoffbahnen mit Hilfe eines beheizten Siegelwerkzeugs (7) entsprechend Figur 1 derart gegeneinander gesiegelt, daß die vereinzelten Dosiseinheiten (5) in Kompartimenten (8) eingesiegelt werden und vollständig von Siegelnähten bzw. Siegelflächen (9) umgeben sind. In einem weiteren Verfahrensschritt werden durch eine Stanzvorrichtung (12) Perforationen zwischen den Kompartimenten (8) eingestanzt. In einem weiteren Verfahrensschritt können Primärverpackungseinheiten (11) durch eine zweite Querschneide- oder stanzvorrichtung vereinzelt werden.A manufacturing method according to the invention is shown schematically in Fig. 2. The ones described here Process steps can be supplemented if necessary. The procedure contains the provision of a laminate in one process step (13) from the web-like, film or wafer-like dosage form (4) and a carrier film (14), from which in one further step with a punching device (15) the dose units (5) are punched out without the carrier film (14) is punched through. In a further step the punched laminate (13) with the help of rolls or Pliers advantages (17) over an edge or deflection shaft (18) see above deflected that the dose units (5) from the carrier film Loosen (14). If necessary, this can also be done additionally a scraper (16) can be used. In a further step a packaging material top web (1) and a - lower web (2) without cold or hot deformation over one each Deflection shaft (3) brought together, at the same time the dose units (5) detaching from the carrier film (14) be guided between the two packaging material webs (1 and 2). In a further process step, the two packaging material webs with the help of a heated sealing tool (7) accordingly Figure 1 sealed against each other so that the isolated Dose units (5) sealed in compartments (8) and completely of sealing seams or sealing surfaces (9) are surrounded. In a further step perforations between a punching device (12) the compartments (8) are stamped. In a further step can primary packaging units (11) by a second cross cutting or punching device can be separated.
Claims (4)
- Process for manufacturing a primary packaging unit for film-like or wafer-like administration forms for oral application with a section of an upper web of packaging material (1) and of a lower web of packaging material (2), with a plurality of dosage units (5) being sealed in flat compartments (8), and perforations being provided between said compartments, characterized in that the film-like or wafer-like administration form is provided by a web-like laminate comprising a carrier sheet, that the dosage units are punched out of the laminate and subsequently the punched-out laminate (13) is advanced and diverted in such a way that the dosage units (5) become detached from the carrier sheet (14) and are led between the packaging material webs (1, 2), and that subsequently the latter (1, 2) are sealed to each other in sections in such a way that compartments (8) comprising dosage units (5) are formed.
- Process according to Claim 1, characterized in that for partitioning off of the dosage units, the laminate (13) is drawn from a supply roll by means of pulling devices (17) in the form of rolls or tongs, is punched and led around the edge or the deflecting roll (18).
- Process according to Claim 1, characterized in that the webs of packaging material (1, 2) are conveyed on top of one another by means of one deflecting roll (3) per web while simultaneously the dosage units (5) which are becoming detached from the carrier film (14) are pushed between the two webs of packaging material (1, 2).
- Process according to Claim 1, characterized in that in a further step, individual primary packaging units (11) are severed by means of a cross-cutting or punching device.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19800682 | 1998-01-10 | ||
DE19800682A DE19800682B4 (en) | 1998-01-10 | 1998-01-10 | Process for producing a primary packaging for film or wafer-shaped administration forms |
PCT/EP1999/000020 WO1999035051A1 (en) | 1998-01-10 | 1999-01-05 | Primary packaging unit for film-like or oblate-like administered shapes |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1045799A1 EP1045799A1 (en) | 2000-10-25 |
EP1045799B1 true EP1045799B1 (en) | 2002-10-23 |
Family
ID=7854295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99902517A Expired - Lifetime EP1045799B1 (en) | 1998-01-10 | 1999-01-05 | Primary packaging unit for film-like or oblate-like administered shapes |
Country Status (24)
Country | Link |
---|---|
US (1) | US6655112B1 (en) |
EP (1) | EP1045799B1 (en) |
JP (1) | JP3947358B2 (en) |
KR (1) | KR100515699B1 (en) |
AT (1) | ATE226547T1 (en) |
AU (1) | AU736498B2 (en) |
CA (1) | CA2317491C (en) |
CZ (1) | CZ293339B6 (en) |
DE (2) | DE19800682B4 (en) |
DK (1) | DK1045799T3 (en) |
ES (1) | ES2188126T3 (en) |
HK (1) | HK1030917A1 (en) |
HU (1) | HU225551B1 (en) |
IL (1) | IL137184A (en) |
MY (1) | MY124591A (en) |
NO (1) | NO325407B1 (en) |
NZ (1) | NZ505340A (en) |
PL (1) | PL195971B1 (en) |
PT (1) | PT1045799E (en) |
SK (1) | SK285576B6 (en) |
TR (1) | TR200001897T2 (en) |
TW (1) | TW385293B (en) |
WO (1) | WO1999035051A1 (en) |
ZA (1) | ZA99129B (en) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10008165A1 (en) * | 2000-02-23 | 2001-08-30 | Lohmann Therapie Syst Lts | Packaging of sheet-like objects with improved tear properties |
DE10102818A1 (en) * | 2001-01-23 | 2002-08-08 | Lohmann Therapie Syst Lts | Primary packaging unit for several isolated film platelets as dosage forms |
DE10144287A1 (en) * | 2001-09-08 | 2003-04-03 | Lohmann Therapie Syst Lts | Method for the electrostatic fixing of sheet-like objects on a base |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US7910789B2 (en) * | 2002-05-07 | 2011-03-22 | Polyremedy, Inc. | Method for treating wound, dressing for use therewith and apparatus and system for fabricating dressing |
US8407065B2 (en) * | 2002-05-07 | 2013-03-26 | Polyremedy, Inc. | Wound care treatment service using automatic wound dressing fabricator |
CN1747656B (en) * | 2002-07-22 | 2011-05-04 | 莫诺索尔克斯有限公司 | Packaging and dispensing of rapid dissolve dosage form |
DE10249705A1 (en) | 2002-09-16 | 2004-04-01 | Lts Lohmann Therapie-Systeme Ag | Individual packaging method for oral medicament wafers has wafer lengths separated from carrier foil and wafer film laminate fed between packaging webs sealed together for providing packaging bag |
JP4180054B2 (en) * | 2002-09-16 | 2008-11-12 | エルテーエス ローマン テラピー−ジステーメ アーゲー | Method and device for production of primary individual packaging of wafers |
EP1611027A1 (en) * | 2002-12-27 | 2006-01-04 | Noven Pharmaceuticals, Inc. | Product retention package |
JP4413925B2 (en) | 2003-07-25 | 2010-02-10 | エルテーエス ローマン テラピー−ジステーメ アーゲー | Wafer fixing and marking |
DE102004017030A1 (en) * | 2004-04-02 | 2005-10-20 | Schering Ag | Flat system for use in the oral cavity, e.g. for transmucosal drug delivery, comprises an intermediate, active agent-containing layer sealed between two covering layers of higher surface area |
WO2006020174A2 (en) * | 2004-07-16 | 2006-02-23 | Polyremedy, Inc. | Wound dressing and apparatus for manufacturing |
US7607834B2 (en) * | 2004-08-02 | 2009-10-27 | R.P. Scherer Technologies, Inc. | Peelable pouch containing a single or multiple dosage forms and process of making same |
US20060104910A1 (en) * | 2004-11-15 | 2006-05-18 | Keith Lerner | Over dosage indicating medicated film strip |
US20060207911A1 (en) * | 2005-03-15 | 2006-09-21 | Bullock John D | Emergency medical treatment system |
DE102005042374B3 (en) * | 2005-09-07 | 2006-10-05 | Lts Lohmann Therapie-Systeme Ag | Packaging unit for containing hygroscopic film-like materials, has separating material which adheres less to film-like material on one side than on other side |
JP2008037460A (en) * | 2006-08-07 | 2008-02-21 | Kyukyu Yakuhin Kogyo Kk | Tablet container and manufacturing method of packaging material using tablet container |
DE102006041921A1 (en) * | 2006-09-07 | 2008-03-27 | Lts Lohmann Therapie-Systeme Ag | Packaging for active substance-containing films and process for their preparation |
JP5229659B2 (en) * | 2006-11-13 | 2013-07-03 | パウダーテック株式会社 | Sheet feeding apparatus and sheet packaging machine using the same |
CA2674876A1 (en) * | 2007-01-10 | 2008-07-17 | Polyremedy, Inc. | Wound dressing with controllable permeability |
NZ578408A (en) | 2007-01-24 | 2011-10-28 | Schur Internat A S | Medium-filled packaging apparatus that provides a package with unsealed longitudinal area |
DE502008001671D1 (en) * | 2007-08-21 | 2010-12-09 | Lohmann Therapie Syst Lts | PROCESS FOR MULTI-PURPOSE PACKAGING OF TRANSDERMAL THERAPEUTIC PAVERS |
US8175941B2 (en) | 2007-11-19 | 2012-05-08 | Codestreet, Llc | Method and system for developing and applying market data scenarios |
US7614202B2 (en) * | 2007-11-27 | 2009-11-10 | Atlas Vac Machine Co., Llc | Sealer and interchangeable tooling therefor |
US20100241447A1 (en) * | 2008-04-25 | 2010-09-23 | Polyremedy, Inc. | Customization of wound dressing using rule-based algorithm |
KR20100135277A (en) * | 2008-04-25 | 2010-12-24 | 에르테에스 로만 테라피-시스테메 아게 | Patch transfer and inspection device |
US8237009B2 (en) * | 2008-06-30 | 2012-08-07 | Polyremedy, Inc. | Custom patterned wound dressings having patterned fluid flow barriers and methods of manufacturing and using same |
US8247634B2 (en) * | 2008-08-22 | 2012-08-21 | Polyremedy, Inc. | Expansion units for attachment to custom patterned wound dressings and custom patterned wound dressings adapted to interface with same |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
WO2012149326A1 (en) | 2011-04-29 | 2012-11-01 | Massachusetts Institute Of Technology | Layer processing for pharmaceuticals |
ES2436535B1 (en) * | 2013-07-12 | 2014-10-08 | Ulma Packaging Technological Center, S.Coop. | Product wrapping machine and operation method for a product wrapping machine |
TWI576286B (en) * | 2014-01-09 | 2017-04-01 | Jung Hua Shao | Injection of the packaging mechanism |
KR101443362B1 (en) * | 2014-02-17 | 2014-09-29 | (주)경성화인켐 | Complex Flim Manufacturing Method and Apparatus |
WO2015179461A1 (en) | 2014-05-20 | 2015-11-26 | Massachusetts Institute Of Technology | Plasticity induced bonding |
KR20230137362A (en) | 2016-05-05 | 2023-10-04 | 어퀘스티브 테라퓨틱스, 아이엔씨. | Enhanced delivery epinephrine compositions |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
CN106829009A (en) * | 2016-12-26 | 2017-06-13 | 全越 | The banding of full-automatic horizontal four abnormity packing machine |
CN107323714B (en) * | 2017-07-24 | 2022-10-18 | 苏州铃兰医疗用品有限公司 | Packaging and film sealing device for alcohol cotton sheets |
DE102017006991B4 (en) | 2017-07-26 | 2020-02-27 | Lts Lohmann Therapie-Systeme Ag | Device and method for producing sealed edge bags |
CN109229536B (en) * | 2018-08-06 | 2020-09-11 | 福建铭发水产开发有限公司 | Orderly-arranged batch bagging mechanism and method for roasted eel blocks after roasting |
CN109621649B (en) * | 2018-11-23 | 2023-12-26 | 晋江市神奇生物科技有限公司 | Mildew-proof dry tablet and production process thereof |
CN109573135B (en) * | 2018-12-14 | 2024-04-26 | 龚涛 | Cake food cutting mechanism with film-coated package, manufacturing equipment and cutting method |
EP3828089A1 (en) * | 2019-11-26 | 2021-06-02 | Swedish Match North Europe AB | An apparatus and a method for portion packing of pouched products for oral use and a pouched product for oral use |
CN111114888B (en) * | 2020-01-14 | 2024-04-26 | 上海小松包装机械有限公司 | Tracking and arranging lifting device |
CN112918723A (en) * | 2021-01-27 | 2021-06-08 | 福建华赢化工有限公司 | Method and device for manufacturing mildew-proof bag |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2836291A (en) * | 1956-08-13 | 1958-05-27 | Pad Y Wax Company Inc | Edible strip package and method of making same |
US3007848A (en) * | 1958-03-12 | 1961-11-07 | Vol Pak Inc | Method of forming an edible medicinal wafer strip package |
US3145112A (en) | 1958-09-09 | 1964-08-18 | Reynolds Metals Co | Food package |
US3596428A (en) * | 1968-10-07 | 1971-08-03 | American Maize Prod Co | Packaging process and apparatus |
US4009239A (en) * | 1973-07-12 | 1977-02-22 | Bowen Max E | Method of forming tablets with separators of sheet material |
DE2432925C3 (en) * | 1974-07-05 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | Film-shaped medicinal products |
US3978637A (en) * | 1975-10-24 | 1976-09-07 | Diamond Crystal Salt Company | Method and apparatus for making packet assemblies |
US4349531A (en) * | 1975-12-15 | 1982-09-14 | Hoffmann-La Roche Inc. | Novel dosage form |
US4307555A (en) * | 1975-12-15 | 1981-12-29 | Hoffmann-La Roche Inc. | System for producing dosage forms |
DE2746414A1 (en) * | 1977-10-15 | 1979-04-26 | Gerlach Eduard Chem Fab | Foil-like tape for dispensing measured amts. of substance - consisting of the substance, binding agent and adjuvants, tape length being proportional to weight of substance |
DE7931081U1 (en) * | 1979-10-31 | 1980-04-10 | Evers Hartmut Dr | Multiple flat bags |
US4789415A (en) * | 1983-01-24 | 1988-12-06 | Faasse Jr Adrian L | Pharmaceutical packaging machine |
US4884563A (en) * | 1985-03-01 | 1989-12-05 | Ferris Mfg. Corp. | Non-stretching wound dressing and method for making same |
US4849246A (en) * | 1985-10-09 | 1989-07-18 | Wolfgang Schmidt | Process for producing an administration or dosage form for drugs, reagents or other active ingredients |
US4841712A (en) * | 1987-12-17 | 1989-06-27 | Package Service Company, Inc. | Method of producing sealed protective pouchs with premium object enclosed therein |
DE59007596D1 (en) * | 1989-05-24 | 1994-12-08 | Sig Schweiz Industrieges | Process and device for the continuous production of packs. |
US5185983A (en) * | 1992-03-02 | 1993-02-16 | Slater John W | Wafer sealer |
CA2177113A1 (en) * | 1995-05-23 | 1996-11-24 | Takayuki Yamaguchi | Method and apparatus of producing sheet wrapping body |
SE9502370D0 (en) | 1995-06-30 | 1995-06-30 | Astra Ab | Blister pack, especially for drugs, as well as method and device in manufacturing the same |
US5648136A (en) * | 1995-07-11 | 1997-07-15 | Minnesota Mining And Manufacturing Co. | Component carrier tape |
US5806284A (en) * | 1997-03-03 | 1998-09-15 | Apothecus Pharmaceutical Corp. | Method and system for producing sealed packages of a film which is dissolved in a body fluid |
US5935613A (en) * | 1998-05-21 | 1999-08-10 | General Mills, Inc. | Rotary molding apparatus for molding food |
-
1998
- 1998-01-10 DE DE19800682A patent/DE19800682B4/en not_active Expired - Fee Related
- 1998-12-31 TW TW087121942A patent/TW385293B/en not_active IP Right Cessation
-
1999
- 1999-01-05 WO PCT/EP1999/000020 patent/WO1999035051A1/en active IP Right Grant
- 1999-01-05 ES ES99902517T patent/ES2188126T3/en not_active Expired - Lifetime
- 1999-01-05 AU AU22779/99A patent/AU736498B2/en not_active Ceased
- 1999-01-05 IL IL13718499A patent/IL137184A/en not_active IP Right Cessation
- 1999-01-05 TR TR2000/01897T patent/TR200001897T2/en unknown
- 1999-01-05 US US09/582,889 patent/US6655112B1/en not_active Expired - Lifetime
- 1999-01-05 DE DE59903158T patent/DE59903158D1/en not_active Expired - Lifetime
- 1999-01-05 DK DK99902517T patent/DK1045799T3/en active
- 1999-01-05 SK SK1022-2000A patent/SK285576B6/en not_active IP Right Cessation
- 1999-01-05 HU HU0101308A patent/HU225551B1/en not_active IP Right Cessation
- 1999-01-05 AT AT99902517T patent/ATE226547T1/en active
- 1999-01-05 PT PT99902517T patent/PT1045799E/en unknown
- 1999-01-05 CZ CZ20002422A patent/CZ293339B6/en not_active IP Right Cessation
- 1999-01-05 KR KR10-2000-7007380A patent/KR100515699B1/en not_active IP Right Cessation
- 1999-01-05 CA CA002317491A patent/CA2317491C/en not_active Expired - Fee Related
- 1999-01-05 JP JP2000527466A patent/JP3947358B2/en not_active Expired - Fee Related
- 1999-01-05 PL PL99341811A patent/PL195971B1/en unknown
- 1999-01-05 NZ NZ505340A patent/NZ505340A/en not_active IP Right Cessation
- 1999-01-05 EP EP99902517A patent/EP1045799B1/en not_active Expired - Lifetime
- 1999-01-08 MY MYPI99000078A patent/MY124591A/en unknown
- 1999-01-08 ZA ZA9900129A patent/ZA99129B/en unknown
-
2000
- 2000-07-07 NO NO20003528A patent/NO325407B1/en not_active IP Right Cessation
-
2001
- 2001-03-14 HK HK01101835A patent/HK1030917A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1045799B1 (en) | Primary packaging unit for film-like or oblate-like administered shapes | |
EP1799579B1 (en) | Peelable child-resistant packaging for wafer pharmaceutical forms | |
EP2059455B1 (en) | Packaging for films which contain active substances, and method for producing it | |
EP0703157B1 (en) | Blister package | |
EP1131260B1 (en) | Method and device for dispensing flat forms | |
EP1799583B1 (en) | Non-reclosable package for products that are hazardous to health | |
DE69001028T2 (en) | SANDWICH BLISTER FOR TABLETS AND THE LIKE. | |
EP1947027B1 (en) | Blister packages and method of temporary storage of products | |
EP1234781A1 (en) | Child-resistant packaging for tablets | |
DE202004021140U1 (en) | Medicine pack has blister units with blister strip connected to protective case capable to be unfolded or opened out, and outer package for receiving the blister units and configured so that pack content is fixed in outer package inside | |
EP1056673A1 (en) | Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pile | |
DE10008165A1 (en) | Packaging of sheet-like objects with improved tear properties | |
DE29823463U1 (en) | Primary packaging unit for film or wafer-like dosage forms | |
WO2006056161A1 (en) | Primary packaging unit for flat administration forms | |
EP0637444B1 (en) | Packing device for tablets and like articles | |
EP1985550A1 (en) | Packaging unit for medicines and method for its manufacture | |
EP3125851B1 (en) | Use of a container for storing contraceptive tablets | |
WO2020165267A1 (en) | Child-resistant packaging | |
MXPA00006759A (en) | Primary packaging unit for film-like or oblate-like administered shapes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000629 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20010319 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
REF | Corresponds to: |
Ref document number: 226547 Country of ref document: AT Date of ref document: 20021115 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN |
|
REF | Corresponds to: |
Ref document number: 59903158 Country of ref document: DE Date of ref document: 20021128 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20030400215 Country of ref document: GR |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20030218 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20030120 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2188126 Country of ref document: ES Kind code of ref document: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20030724 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20101214 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 59903158 Country of ref document: DE Ref country code: DE Ref legal event code: R082 Ref document number: 59903158 Country of ref document: DE Representative=s name: ROLF DIETER FLACCUS, DE |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20120124 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20120105 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20120111 Year of fee payment: 14 Ref country code: GR Payment date: 20120119 Year of fee payment: 14 Ref country code: DK Payment date: 20120119 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20130705 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: ML Ref document number: 20030400215 Country of ref document: GR Effective date: 20130802 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130705 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130802 Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130105 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130131 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20150129 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20150121 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20150121 Year of fee payment: 17 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130105 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160131 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20160201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160106 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160201 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20170120 Year of fee payment: 19 Ref country code: FR Payment date: 20170120 Year of fee payment: 19 Ref country code: CH Payment date: 20170119 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20170119 Year of fee payment: 19 Ref country code: AT Payment date: 20170123 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20170113 Year of fee payment: 19 Ref country code: IT Payment date: 20170124 Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 59903158 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 226547 Country of ref document: AT Kind code of ref document: T Effective date: 20180105 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20180105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180801 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180131 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20180928 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180131 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180105 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180105 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180105 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20190730 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180106 |